[go: up one dir, main page]

MX2012013332A - Preparacion de intermediarios de posaconazol. - Google Patents

Preparacion de intermediarios de posaconazol.

Info

Publication number
MX2012013332A
MX2012013332A MX2012013332A MX2012013332A MX2012013332A MX 2012013332 A MX2012013332 A MX 2012013332A MX 2012013332 A MX2012013332 A MX 2012013332A MX 2012013332 A MX2012013332 A MX 2012013332A MX 2012013332 A MX2012013332 A MX 2012013332A
Authority
MX
Mexico
Prior art keywords
preparation
sub
posaconazole
intermediates
posaconazole intermediates
Prior art date
Application number
MX2012013332A
Other languages
English (en)
Other versions
MX338514B (es
Inventor
Dominic De Souza
Shreerang V Joshi
Sachin Bhuta
Abhinay C Pise
Dattatraya N Chavan
Shashikant D Metkar
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX2012013332A publication Critical patent/MX2012013332A/es
Publication of MX338514B publication Critical patent/MX338514B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de un compuesto quiral de la fórmula (IX) o una sal del mismo, en donde Y1 y Y2 son independientemente E o CI, de preferencia F, al compuesto cristalino de la fórmula (IX) como tal, y a su uso para la preparación de un agente antimicótico.
MX2012013332A 2010-05-19 2011-05-18 Preparacion de intermediarios de posaconazol. MX338514B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10163215 2010-05-19
PCT/EP2011/058036 WO2011144656A1 (en) 2010-05-19 2011-05-18 Preparation of posaconazole intermediates

Publications (2)

Publication Number Publication Date
MX2012013332A true MX2012013332A (es) 2013-02-01
MX338514B MX338514B (es) 2016-04-20

Family

ID=42341764

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013332A MX338514B (es) 2010-05-19 2011-05-18 Preparacion de intermediarios de posaconazol.

Country Status (10)

Country Link
US (1) US9073904B2 (es)
EP (1) EP2571868B1 (es)
JP (1) JP2013532131A (es)
CN (1) CN102892762B (es)
AU (1) AU2011254657B2 (es)
BR (1) BR112012029226A2 (es)
CA (1) CA2798007C (es)
MX (1) MX338514B (es)
RU (1) RU2580318C2 (es)
WO (1) WO2011144656A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2571869B1 (en) 2010-05-19 2015-09-23 Sandoz AG Purification of posaconazole and posaconazole intermediates
CN102892750B (zh) 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
EP2571871B1 (en) 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
EP2746266A1 (en) * 2012-12-19 2014-06-25 Basf Se New substituted triazoles and imidazoles and their use as fungicides
CN103086885B (zh) * 2013-02-28 2015-04-01 天津大学仁爱学院 一种泊沙康唑中间体的制备方法
EP2789610A1 (en) * 2013-04-10 2014-10-15 Sandoz Ag Purification of Posaconazole Intermediates
CN105777720B (zh) * 2014-12-26 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种泊沙康唑中间体的新晶型及制备方法
JP7054381B2 (ja) * 2015-09-23 2022-04-13 バイオコン・リミテッド 結晶形態のポサコナゾール中間体および非晶質ポサコナゾールの調製のためのプロセス
CN105622413B (zh) * 2016-01-14 2017-11-24 宁波新凯生物科技有限公司 2‑[2‑(2，4‑二氟苯基)烯丙基]‑1，3‑丙二酸二乙酯的合成方法
CN105753693B (zh) * 2016-03-30 2017-12-22 宁波新凯生物科技有限公司 2‑甲基丙酸‑[(2s)‑4‑(2，4‑二氟苯基)‑2‑羟甲基‑4‑戊烯‑1‑基]酯的合成方法
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2，4-二氟苯基)-2-丙烯-1-基]-1，3-丙二醇的合成方法
CN105732310B (zh) * 2016-03-30 2018-01-23 宁波新凯生物科技有限公司 2‑[2‑(2，4‑二氟苯基)‑2‑丙烯‑1‑基]‑1，3‑丙二醇的合成方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307232D0 (en) * 1983-03-16 1983-04-20 Pfizer Ltd Antifungal agents
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
US5595872A (en) 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5403937A (en) 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5349099A (en) * 1993-12-13 1994-09-20 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
JP2834889B2 (ja) * 1993-12-21 1998-12-14 シェーリング コーポレイション テトラヒドロフラン抗真菌剤
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5693626A (en) 1993-12-21 1997-12-02 Schering Corporation Tetrahydrofuran antifungals
US5710154A (en) 1993-12-21 1998-01-20 Schering Corporation Tetrahydrofuran antifungals
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
US5486625A (en) * 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
US5616777A (en) 1995-04-19 1997-04-01 Schering Corporation Chiral hydrazine derivatives
ES2199291T3 (es) 1995-06-02 2004-02-16 Schering Corporation Antifungicos de tetrahidrofurano.
IL118668A0 (en) * 1995-06-19 1996-10-16 Schering Corp Tetrahydrofuran antifungals
NZ325566A (en) 1995-12-20 1999-05-28 Schering Corp Process for preparing a crystalline chiral hydroxy ester intermediate for the synthesis of antifungal agents
CN1209116A (zh) 1995-12-20 1999-02-24 先灵公司 制备酰肼类化合物的方法
EP0885394B1 (de) 1996-03-08 2000-08-16 Octapharma AG Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5972381A (en) 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
BR9812866A (pt) 1997-10-07 2000-08-08 Schering Corp Polimorfo antifúngico cristalino
US6713481B1 (en) 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
US6355801B1 (en) 1999-11-08 2002-03-12 Schering Corporation Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine
ATE298325T1 (de) 1999-11-08 2005-07-15 Schering Corp Verfahren zur herstellung von n-(4-hydroxyphenyl)-n'-(4'-aminophenyl)-piperaz ne
CN100415234C (zh) 2001-04-03 2008-09-03 先灵公司 生物利用度提高的抗真菌组合物
ES2296131T3 (es) 2004-02-02 2008-04-16 Pfizer Products Incorporated Procedimiento para la preparacion de 1-(2s,3s)-2-bencidril-n-(5-terc-butil-2-metoxibencil)quinuclidin-3-amina.
EP1761247A1 (en) 2004-05-28 2007-03-14 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole
JP2008505107A (ja) 2004-07-01 2008-02-21 シェーリング　コーポレイション Ｎｋ１アンタゴニストとしてのピペリジン誘導体
TW200811116A (en) 2006-04-20 2008-03-01 Glaxo Group Ltd Compounds
SG170047A1 (en) 2006-05-30 2011-04-29 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations
CN102702185A (zh) 2007-04-27 2012-10-03 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐的结晶
US7795254B2 (en) 2007-10-29 2010-09-14 Amgen Inc. Benzomorpholine derivatives and methods of use
WO2009129297A1 (en) 2008-04-15 2009-10-22 Schering Corporation Semi-solid oral pharmaceutical compositions
WO2009141837A2 (en) * 2008-05-21 2009-11-26 Ind-Swift Laboratories Limited Process for preparing posaconazole and intermediates thereof
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2393480A1 (en) 2009-02-05 2011-12-14 Targeted Delivery Technologies Limited Methods of reducing the proliferation and viability of microbial agents
EP2571871B1 (en) 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
CN102892750B (zh) 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
EP2571869B1 (en) 2010-05-19 2015-09-23 Sandoz AG Purification of posaconazole and posaconazole intermediates
CN104379132A (zh) 2012-06-14 2015-02-25 桑多斯股份公司 包含结晶泊沙康唑的药物组合物

Also Published As

Publication number Publication date
BR112012029226A2 (pt) 2015-10-20
CN102892762B (zh) 2016-04-20
CA2798007C (en) 2018-10-23
RU2012154807A (ru) 2014-06-27
MX338514B (es) 2016-04-20
AU2011254657B2 (en) 2016-02-04
CN102892762A (zh) 2013-01-23
JP2013532131A (ja) 2013-08-15
CA2798007A1 (en) 2011-11-24
AU2011254657A1 (en) 2012-12-20
EP2571868A1 (en) 2013-03-27
WO2011144656A1 (en) 2011-11-24
US20130203994A1 (en) 2013-08-08
US9073904B2 (en) 2015-07-07
RU2580318C2 (ru) 2016-04-10
EP2571868B1 (en) 2016-05-04

Similar Documents

Publication Publication Date Title
MX2012013332A (es) Preparacion de intermediarios de posaconazol.
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
PH12013500365A1 (en) Anti-infective agents and uses thereof
TN2014000003A1 (en) Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
MY160785A (en) Manufacturing process for pyrimidine derivatives
WO2010111436A3 (en) Antiviral compounds and uses thereof
TW201144305A (en) Fungicidal oximes and hydrazones
PH12014500083B1 (en) Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
MX2014001671A (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]- 2-aluiniloxi-etil}-1h[1,2,4]triazol sustituidos.
MY150778A (en) Fused heterocyclic compound
MX2010005109A (es) Compuestos herbicidas.
MY160392A (en) Triptolide prodrugs
PH12013502061A1 (en) Herbicidal compounds
IN2014CN04449A (es)
MX337804B (es) Proceso para la preparacion de hidrazinas quirales.
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
IN2014MN01671A (es)
WO2011135586A3 (en) Process for the preparation of chiral beta amino carboxamide derivatives
IN2012DN02000A (es)
MX2013002656A (es) Nuevo proceso.
WO2012150183A8 (en) Crystalline sodium salt of an hiv integrase inhibitor
WO2012008763A3 (en) Composition for preventing hair loss and stimulating hair growth
CL2009000346A1 (es) Compuestos derivados de pirimidilmetilsulfonamida; procedimiento para preparar dichos compuestos; compuesto intermediario de formula ixa; composicion agroquimica; metodo para combatir hongos daninos fitopatogenos, y uso de dichos compuestos.
MX2013007359A (es) Inhibidores de hepatitis c y usos de los mismos.

Legal Events

Date Code Title Description
FG Grant or registration